These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3840275)

  • 1. Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
    Specht L; Nissen NI; Walbom-Jørgensen S
    Scand J Haematol; 1985 Aug; 35(2):166-73. PubMed ID: 3840275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
    Specht L; Nissen NI
    Scand J Haematol; 1986 Apr; 36(4):367-75. PubMed ID: 3754976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.
    Brice P; Colin P; Berger F; de Kerviler E; Diviné M; Bouaffia F; Kerneis Y; Blanc M; Lepage E; Fermé C;
    Cancer; 2001 Aug; 92(3):453-9. PubMed ID: 11505388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)].
    Denz H; Lechleitner M; Peschel C; Peer L; Huber H
    Wien Klin Wochenschr; 1983 May; 95(10):326-32. PubMed ID: 6688488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
    Hagemeister FB; Fuller LM; Sullivan JA; North L; Velasquez W; Conrad FG; McLaughlin P; Butler JJ; Shullenberger CC
    Radiology; 1981 Dec; 141(3):783-9. PubMed ID: 6895415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
    Ferrant A; Hamoir V; Binon J; Michaux JL; Sokal G
    Cancer; 1985 Jan; 55(2):317-22. PubMed ID: 2578082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
    Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
    Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
    Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.
    Fuller LM; Hagemeister FB; North LB; McLaughlin P; Velasquez WS; Cabanillas F
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):683-92. PubMed ID: 3280532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
    Neumann E
    Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
    Longo DL; Russo A; Duffey PL; Hubbard SM; Glatstein E; Hill JB; Jaffe ES; Young RC; DeVita VT
    J Clin Oncol; 1991 Feb; 9(2):227-35. PubMed ID: 1988570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
    Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
    De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
    Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment.
    Goodman R; Mauch P; Piro A; Rosenthal D; Goldstein M; Tullis J; Hellman S
    Cancer; 1977 Jul; 40(1):84-9. PubMed ID: 406981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.